Danaher Co. (NYSE:DHR) Stock Position Decreased by Arcadia Investment Management Corp MI

Arcadia Investment Management Corp MI cut its stake in shares of Danaher Co. (NYSE:DHR) by 3.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,636 shares of the conglomerate’s stock after selling 367 shares during the quarter. Arcadia Investment Management Corp MI’s holdings in Danaher were worth $2,671,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Centricity Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter worth $224,000. ING Groep NV boosted its stake in shares of Danaher by 59.8% during the 4th quarter. ING Groep NV now owns 137,402 shares of the conglomerate’s stock worth $31,541,000 after acquiring an additional 51,438 shares in the last quarter. Flossbach Von Storch SE lifted its holdings in shares of Danaher by 1.2% in the fourth quarter. Flossbach Von Storch SE now owns 3,710,738 shares of the conglomerate’s stock valued at $851,800,000 after purchasing an additional 44,490 shares in the last quarter. O Brien Greene & Co. Inc boosted its position in shares of Danaher by 0.5% in the fourth quarter. O Brien Greene & Co. Inc now owns 36,209 shares of the conglomerate’s stock worth $8,312,000 after buying an additional 184 shares during the period. Finally, Dash Acquisitions Inc. grew its holdings in shares of Danaher by 3.4% during the fourth quarter. Dash Acquisitions Inc. now owns 73,950 shares of the conglomerate’s stock valued at $18,328,000 after buying an additional 2,419 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

DHR has been the subject of several research analyst reports. Raymond James reissued a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Guggenheim initiated coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Robert W. Baird decreased their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research note on Thursday, October 31st. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 11.10% of the company’s stock.

Danaher Stock Up 1.5 %

DHR stock opened at $208.10 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a fifty day simple moving average of $227.21 and a 200 day simple moving average of $247.52. The firm has a market cap of $150.31 billion, a PE ratio of 39.41, a PEG ratio of 2.61 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm posted $2.09 EPS. Sell-side analysts anticipate that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.62%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.